Suchergebnisse - "Giol, Jordi"

PubPharm (4)

1

Bayesian Analysis of the ICAT·COVID Randomized Clinical Trial

enthalten in: Clinical therapeutics | 2024

von Malchair, P. | Villoria, J. | Giol, J. | +3

2

Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia : A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Malchair, P. | Giol, J. | García, V. | +15

CommentIn: Infect Dis (Lond). 2023 Jun;55(6):444-445. - PMID 37067851

3

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation : study protocol (ICAT-COVID)

enthalten in: Trials | 2022

von Malchair, P. | Otero, A. | Giol, J. | +34

4

Exceptional treatment of COVID-19 pneumonia with icatibant

enthalten in: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias | 2022

von Giol, J. | Jacob, J. | Llopis, F. | +3

1
[1]